© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About 82.59% of BNTC shares are held by financial institutions. TOWER RESEARCH CAPITAL LLC (TRC) is the top corporate investor, holding 0 shares valued at -. A 0% stake in Benitec Biopharma Inc. is owned by the company. VIRTU FINANCIAL LLC owns 0 shares valued at -, which translates its holding of 0% of the stake in the company.
Among the BNTC insiders holding of 4.39% of the stake in company, , , holds the largest shares of -. , , is the second largest BNTC insider with ownership of - shares. , , stands third with possession of - shares of that stake.
A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own BNTC shares is 28, representing 82.59% of the company's common stock.
TOWER RESEARCH CAPITAL LLC (TRC), in the last quarter, reduced its stake in BNTC by -100% restricting it's holding to 0 shares of worth nearly -. VIRTU FINANCIAL LLC also lessened -100% of the BNTC shares from its portfolio, reducing its holding to 0 shares of worth -. PRIVATE ADVISOR GROUP, LLC also shunned BNTC shares holding by -100% last quarter which brought its holding to 0 shares worth -.
As per its latest 13F filing, N/A increased its stake in BNTC by N/A in the last quarter. The institutional holder raised its holding to - shares having worth more than -. N/A also added N/A more shares of BNTC to its portfolio, raising its holding to - shares of worth -. N/A also increased its BNTC shares holding by N/A which brought its holding to - shares worth -.
The insider with the most stakes in BNTC is N/A , N/A at the company. Additionally, BNTC stock is highly held by N/A N/A and N/A N/A among others.
Company executives, directors, and other insiders own 4.39% percent of Benitec Biopharma Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which BNTC insiders have sold stock, totaling 0 shares. Insiders that have sold shares include .
There have been 2 transaction(s) during the past 6-months in which Benitec Biopharma Inc. insiders have bought stock, totalling 4646 shares
Around 1.9M Benitec Biopharma Inc. shares are held by insiders, which represents about 4.39% of BNTC stock.
BNTC N/A, N/A holds the largest portfolio of the company's shares. BNTC shares owned by N/A total nearly -.
TOWER RESEARCH CAPITAL LLC (TRC) is the largest institutional owner in BNTC which holds 0 shares worth - or 0% of the total BNTC shares outstanding followed by VIRTU FINANCIAL LLC with ownership of 0 shares representing 0% of the BNTC ownership. PRIVATE ADVISOR GROUP, LLC is the third largest stakeholder with 0 shares or 0% of the ownership worth more than -.
Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the BNTC is concerned, it is a stock which is not optionable.
Number of BNTC shares short is 38.17K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.
As of today, 19.82M shares of BNTC are outstanding.
Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, BNTC has 3.88M shares in float.
Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for BNTC is 0.98.